SMS Pharmaceuticals post Q2 FY26 consolidated PAT at Rs. 25.31 Cr
Caplin Point Laboratories reports Q2 FY26 consolidated PAT at Rs. 154.45 Cr
Solara Active Pharma Sciences posts Q2 FY26 consolidated loss at Rs. 10.10 Cr
Piramal Pharma posts Q2 FY26 consolidated loss at Rs. 99.22 Cr
Syngene International reports Q2 FY26 consolidated PAT at Rs. 67.1 Cr
Poly Medicure posts Q2 FY26 consolidated net profit at Rs. 91.83 Cr
Alembic announces USFDA final approval for Dasatinib Tablets
Alembic receives FDA final approval for Sumatriptan Injection USP
Zydus Lifesciences secures FDA tentative approval for Olaparib tablets
Sun Pharmaceutical Industries posts consolidated Q2 FY26 PAT higher at Rs. 3,137.09 Cr
A bio-analytical Remote Regulatory Assessment was also conducted from October 30 to November 7, 2025, and concluded with no observations
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes